Cancer Related Pain Dx - Feedback

XMLWordPrintable

    • Type: Hosp Inpt eCQMs - Hospital Inpatient eCQMs
    • Resolution: Answered
    • Priority: Moderate
    • Component/s: None
    • None
    • Beth Sahlmann
    • 814-449-2547
    • VHA
    • Hide
      Thank you for your feedback regarding CMS506v7 Safe Use of Opioids - Concurrent Prescribing. The measure team aligned the denominator exclusion, “Inpatient hospitalizations where patients have cancer pain that begins prior to or during the encounter” with the CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022, that states that “recommendations do not apply to pain related to sickle cell disease or cancer.” We will consider pairing specific cancer diagnoses known to cause significant pain as an exclusion.
      Show
      Thank you for your feedback regarding CMS506v7 Safe Use of Opioids - Concurrent Prescribing. The measure team aligned the denominator exclusion, “Inpatient hospitalizations where patients have cancer pain that begins prior to or during the encounter” with the CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022, that states that “recommendations do not apply to pain related to sickle cell disease or cancer.” We will consider pairing specific cancer diagnoses known to cause significant pain as an exclusion.
    • CMS0506v7
    • We understand the spirit of making this change as cancer is not always painful, however this change to using Cancer related pain Dx may not be the best method to capture the population experiencing pain related to their pain dx.

      We understand the spirit of making this change as cancer is not always painful and cancer diagnoses often persist beyond active treatment and remission periods.  There is also a growing number of people that are cancer survivors but continue to be treated with high dose opioid therapy titrated to current levels when they were experiencing significant pain but has never been successfully tapered and they’ve not been included in LTOT metrics.

      As for cancer related pain diagnoses, we agree that when pain emerges as a symptom it will not appear as an ICD code until there is a level of permanence such as nerve damage, tissue damage, and pain related to treatment and drug-induced, chemo, radiation, and surgical consequences of treatment that become permanent conditions.

      Due to the above, you may be inappropriately including Active Cancers (e.g., bone, pancreatic, large tumors that put pressure on soft tissue, etc.) known to cause significant pain. Have you considered including specific cancer diagnoses, and active cancer treatment in addition to cancer related pain diagnoses for this exclusion?

            Assignee:
            Mathematica EH eCQM Team
            Reporter:
            Beth Sahlmann
            Votes:
            0 Vote for this issue
            Watchers:
            3 Start watching this issue

              Created:
              Updated:
              Resolved:
              Solution Posted On: